OnDemand Trends for the Clinical Trial of Tomorrow
Trends for the Clinical Trial of Tomorrow
Watch one of our best attended NEXT talks on the future of clinical trials. What do you see as the next generation of clinical trial protocols—adaptive, virtual, personalized, biologics, custom randomizations?
Panelists weigh in on topics that they see emerge in the industry and offer insights and predictions on the future of clinical trials.
Sr. Director, Product — RTSM
Daniel H. O’Leary M.D.
Sr. VP, Medical Department
Chief Medical Officer, Core Labs
VP, Digital Transformation
EVP, Professional Services
About Medidata NEXT
Medidata NEXT is the largest annual event series of its kind, and attracts over 3,000 leaders in drug and device development, clinical operations, data management, biostatistics, and digital medicine innovation industries. These professionals gather for networking and learning across six Medidata NEXT conferences in Basel, London, New York, Seoul, Shanghai and Tokyo.
Medidata is The Operating System for Life SciencesTM and precision medicine. Medidata helps pharmaceutical, biotech, medical device and diagnostics companies, and academic researchers accelerate value, minimize risk, and optimize outcomes. More than one million registered users across 1,400 customers and partners access Medidata’s intelligent platform for clinical, commercial, and real-world data insights to create hope for millions of patients. Headquartered in New York City, Medidata has 16 locations around the world and is part of Dassault Systèmes (Euronext Paris: #13065, DSY.PA). Discover more at www.medidata.com, and follow us @Medidata.